x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology entrepreneurship

All Episodes

39:36

E140 | How to leverage AI for better predictions...

AI For Pharma Growth ·

2024/11/20

In this episode of AI for Pharma Growth, Dr. Andree Bates hosts Dr. Louis Rosenberg, founder and CEO of Unanimous AI, to discuss the revolutionary impact of swarm intelligence on group decision-making and forecasting in the pharmaceutical industry and beyond. Dr. Rosenberg explains how Unanimous AI's platforms—Swarm and ThinkScape—enhance the collective wisdom of groups, allowing organisations to make faster, more accurate decisions by harnessing the power of AI-driven group dynamics.The

en

37:40

E139 | Leveraging Ai in pharma supply chain

AI For Pharma Growth ·

2024/11/13

In this episode, we explore the intersection of artificial intelligence (AI) and healthcare supply chains with Philip Ashton, founder and CEO of 7bridges. As healthcare systems globalise, the pharmaceutical supply chain becomes increasingly complex and vulnerable to disruptions. Ashton reveals how AI and real-world data are revolutionising supply chain management, allowing for greater visibility, resilience, and efficiency.We dive into the unique challenges faced by pharmaceutical companies,

en

32:42

E138 | Leveraging AI for Patient Care

AI For Pharma Growth ·

2024/11/06

In this episode, Dr Andree Bates sits down with Dr Jayne Morgan, Vice President of Medical Affairs and On-Air Medical Expert. They discuss the transformative role of artificial intelligence (AI) in patient care, telehealth, and the future of diagnostics. Dr Morgan provides an insider’s perspective on the challenges and ethical concerns facing AI-driven healthcare, from physician burnout to data bias, and explores how these innovations could shape the future of hospitals and patient care.Dr Morgan

en

26:17

E137 | Leveraging AI to assess the outcome of cancer...

AI For Pharma Growth ·

2024/10/30

In this episode, we dive into the future of cancer treatment with Dr. Sola Adeleke, founder and CEO of Curenetics.Dr. Adeleke shares how his company is using artificial intelligence (AI) to predict cancer treatment outcomes and improve the personalisation of cancer therapies, particularly in immunotherapy. We explore the key challenges of current treatment methods, the role of genomics and imaging in precision medicine, and the ethical concerns in AI-driven healthcare decisions.We talk about the

en

23:52

E136 | Rescuing Failed Drug Projects: How Ignota's...

AI For Pharma Growth ·

2024/10/23

In this episode, Dr. Andree Bates speaks with Dr. Jordan Lane, Chief Scientific Officer of Ignota Labs, about how explainable AI is transforming the pharmaceutical industry. They explore how Ignota Labs leverages AI to rescue drug projects that previously failed due to safety concerns. Dr. Lane highlights the groundbreaking technology behind the Safe Path platform, which integrates chem-informatics and bioinformatics to address drug safety issues, potentially bringing valuable but shelved drugs back

en

32:03

E135 | The Role of Government in AI Regulation

AI For Pharma Growth ·

2024/10/15

In this episode of "AI for Pharma Growth" Dr Andree Bates sits down with Ken Pomella, CEO of RevStar, to delve into the intricate balance between innovation and ethical responsibility in the development of AI technologies. They explore the ethical challenges that AI poses, particularly in the pharmaceutical and healthcare sectors, and discuss ways to ensure that AI advances without causing harm. From data privacy concerns to bias in AI systems, the conversation sheds light on how responsible

en

24:33

E134 | The Role of AI in Disrupting Traditional...

AI For Pharma Growth ·

2024/10/08

In this episode of AI for Pharma Growth, Dr. Andree Bates sits down with Cav. Franco Lofranco, CEO of APM Global, to explore how artificial intelligence is revolutionising the healthcare industry, making it more affordable and accessible. They discuss the challenges of the current healthcare system in the United States, including high costs and inequitable access, and highlight how new technology, particularly AI-driven decentralised health-sharing models, is offering innovative solutions. Franco

en

33:31

E133 | How to Ensure a Stronger Supply Chain...

AI For Pharma Growth ·

2024/10/02

In this episode, host Dr. Andree Bates sits down with Raj Bhattacharya, who previously headed the go-to-market function for pharma and life sciences at One Network. Raj shares his extensive background in the pharmaceutical industry, having worked in production, formulations R&D, and supply chain roles for companies like AstraZeneca and Allergan. Raj highlights the key challenges facing pharma supply chains, such as visibility, lead times, and inventory management. He explains how AI can help

en

25:49

E132 | Leveraging AI to Protect Human Vocal Authenticity

AI For Pharma Growth ·

2024/09/25

This episode of AI for Pharma Growth features an interview with Noah Kjos, the Co-Founder and COO of DeepTrust, a company that offers an AI tool to authenticate whether an audio recording was generated by an AI voice or a human voice. Andree and Noah discuss the growing threat of deep fake audio scams and the importance of being able to verify the authenticity of voice communications, particularly in the business world. Noah shares his personal experience with his grandfather being targeted by a

en

30:35

E131 | Leveraging A Robotic Pill for Non-Invasive...

AI For Pharma Growth ·

2024/09/18

This episode of AI for Pharma Growth features an interview with Torrey Smith, the Co-Founder and CEO of Endiatx, a company developing a revolutionary robotic pill that can provide a non-invasive way to observe inside the human body. Torrey explains the journey of Endiatx, progressing from a startup in a Silicon Valley garage to clinical trials and engagement with leading healthcare institutions, including a conversation with the FDA. Endiatx's "PillBot" aims to bridge the gap between traditional

en

25:35

E130 | Leveraging AI in Neuromarketing

AI For Pharma Growth ·

2024/09/11

This episode features an interview with Marco Baldocchi, the founder and CEO of the Marco Baldocchi Group, who specialises in leveraging AI in neuromarketing. Marco discusses his background in marketing and economics, and how a personal experience with buying a car led him to explore the unconscious decision-making processes of consumers. Marco explains how neuromarketing techniques, such as EEG, skin response, and facial recognition, can be used to study the brain and predict consumer behaviour

en

22:23

E129 | Leveraging Wastewater and AI to Predict...

AI For Pharma Growth ·

2024/09/04

In this episode, Dr. Andree Bates speaks to Mariana Matus, the co-founder and CEO of Biobot, a company that is transforming wastewater infrastructure into public health observatories. Mariana explains the concept of wastewater epidemiology, where wastewater samples from communities are collected and analysed for various disease indicators, including COVID-19, influenza, and substances of concern like fentanyl and cocaine. She also discusses how AI plays a crucial role in Biobot's work, allowing

en

32:11

E128 | Leveraging AI for Early Disease Prediction

AI For Pharma Growth ·

2024/08/28

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Xander Kerman Gregory, the Head of Growth at Ubie Health, to discuss the company's innovative work in early disease prediction through the power of artificial intelligence. Ubie Health focussed on user-centric design to dynamically guide patients through a series of carefully selected questions to quickly arrive at the most likely diagnoses. They provide a holistic approach to improving healthcare outcomes by integrating

en

26:56

E127 | Who is using your face? Find out with AI

AI For Pharma Growth ·

2024/08/21

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of synthetic media and its far-reaching consequences across society. They discuss the far-reaching potential ramifications of deep fakes, including case

en

25:51

E126 | The impact of RAG and LLMs on data processing...

AI For Pharma Growth ·

2024/08/14

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to verify facts. Vinoth explains how the use of retrieval-augmented generation (RAG) can help improve the accuracy and relevance of LLM outputs. RAG models

en

23:20

E125 | Using AI to power early detection and provide...

AI For Pharma Growth ·

2024/08/07

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial calcification detection products. Navid & Andree discuss the potential of AI in oncology and cardiology, highlighting the significance of CureMetrix’s FDA

en

29:58

E124 | How AI is being used to tackle global health...

AI For Pharma Growth ·

2024/07/31

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing tech into healthcare, overcoming limited data and infrastructure, the need for collaboration, addressing systemic healthcare issues, and ensuring

en

27:26

E123 | How AI is driving improved clinical, patient,...

AI For Pharma Growth ·

2024/07/24

In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibly high level of accuracy whilst following all medical guidelines. They discuss the importance of technology in improving the pharma industry,

en

29:06

E122 | Encouraging AI Adoption in Teams

AI For Pharma Growth ·

2024/07/17

In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable efficiency gains. Founded with a focus on transforming how teams operate, they integrate advanced AI technologies to streamline tasks and improve

en

36:14

E121 | Predicting The Future With AI

AI For Pharma Growth ·

2024/07/09

In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as a lead developer, with a background in Business Intelligence, has equipped him with the skills needed to build the initial minimum viable version of

en

202 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs